JP6084172B2 - 酸化感受性材料の統合的な触媒による保護 - Google Patents
酸化感受性材料の統合的な触媒による保護 Download PDFInfo
- Publication number
- JP6084172B2 JP6084172B2 JP2013558170A JP2013558170A JP6084172B2 JP 6084172 B2 JP6084172 B2 JP 6084172B2 JP 2013558170 A JP2013558170 A JP 2013558170A JP 2013558170 A JP2013558170 A JP 2013558170A JP 6084172 B2 JP6084172 B2 JP 6084172B2
- Authority
- JP
- Japan
- Prior art keywords
- sensor
- graft
- porous
- indicator
- protective coating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000463 material Substances 0.000 title claims description 95
- 238000007254 oxidation reaction Methods 0.000 title claims description 56
- 230000003647 oxidation Effects 0.000 title claims description 55
- 230000003197 catalytic effect Effects 0.000 title description 14
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 108
- 229910052751 metal Inorganic materials 0.000 claims description 94
- 239000002184 metal Substances 0.000 claims description 94
- 239000003642 reactive oxygen metabolite Substances 0.000 claims description 73
- 238000001727 in vivo Methods 0.000 claims description 56
- 229910052697 platinum Inorganic materials 0.000 claims description 51
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 49
- 238000000034 method Methods 0.000 claims description 40
- 239000010410 layer Substances 0.000 claims description 37
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 36
- 229910052709 silver Inorganic materials 0.000 claims description 36
- 239000004332 silver Substances 0.000 claims description 36
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 31
- 239000008103 glucose Substances 0.000 claims description 31
- 239000011253 protective coating Substances 0.000 claims description 30
- 230000001681 protective effect Effects 0.000 claims description 28
- 238000000576 coating method Methods 0.000 claims description 26
- 238000004544 sputter deposition Methods 0.000 claims description 25
- 239000011248 coating agent Substances 0.000 claims description 24
- 229910052763 palladium Inorganic materials 0.000 claims description 24
- 229920000642 polymer Polymers 0.000 claims description 24
- 230000015556 catabolic process Effects 0.000 claims description 23
- 238000006731 degradation reaction Methods 0.000 claims description 23
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 23
- 229910052737 gold Inorganic materials 0.000 claims description 22
- 239000010931 gold Substances 0.000 claims description 22
- 230000004888 barrier function Effects 0.000 claims description 21
- 239000012491 analyte Substances 0.000 claims description 20
- 229910044991 metal oxide Inorganic materials 0.000 claims description 20
- 150000004706 metal oxides Chemical class 0.000 claims description 20
- 239000000956 alloy Substances 0.000 claims description 19
- 229910045601 alloy Inorganic materials 0.000 claims description 19
- 230000006378 damage Effects 0.000 claims description 18
- 208000005422 Foreign-Body reaction Diseases 0.000 claims description 17
- 206010061218 Inflammation Diseases 0.000 claims description 17
- 239000003054 catalyst Substances 0.000 claims description 16
- 229920002521 macromolecule Polymers 0.000 claims description 14
- 230000005855 radiation Effects 0.000 claims description 14
- 239000007800 oxidant agent Substances 0.000 claims description 13
- 230000002757 inflammatory effect Effects 0.000 claims description 12
- 241001465754 Metazoa Species 0.000 claims description 10
- 230000028709 inflammatory response Effects 0.000 claims description 10
- 230000004054 inflammatory process Effects 0.000 claims description 9
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 8
- 230000007774 longterm Effects 0.000 claims description 7
- 230000008859 change Effects 0.000 claims description 6
- 230000006866 deterioration Effects 0.000 claims description 4
- 238000012544 monitoring process Methods 0.000 claims description 4
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical group OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 claims description 4
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
- 230000006335 response to radiation Effects 0.000 claims 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 168
- 239000007943 implant Substances 0.000 description 34
- 239000000178 monomer Substances 0.000 description 19
- 230000006870 function Effects 0.000 description 18
- 239000000523 sample Substances 0.000 description 18
- 230000000694 effects Effects 0.000 description 16
- 150000002739 metals Chemical class 0.000 description 16
- 239000000243 solution Substances 0.000 description 13
- 239000000126 substance Substances 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 12
- 238000000354 decomposition reaction Methods 0.000 description 10
- 230000035876 healing Effects 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 239000012528 membrane Substances 0.000 description 10
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 9
- 238000001514 detection method Methods 0.000 description 9
- 238000009792 diffusion process Methods 0.000 description 9
- 238000001465 metallisation Methods 0.000 description 9
- 230000008901 benefit Effects 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 239000001301 oxygen Substances 0.000 description 8
- 229910052760 oxygen Inorganic materials 0.000 description 8
- 239000011241 protective layer Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000010408 film Substances 0.000 description 7
- 238000002513 implantation Methods 0.000 description 7
- 230000001590 oxidative effect Effects 0.000 description 7
- 239000011148 porous material Substances 0.000 description 7
- 230000029663 wound healing Effects 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 230000002411 adverse Effects 0.000 description 6
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical group OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 125000006575 electron-withdrawing group Chemical group 0.000 description 6
- 229920001480 hydrophilic copolymer Polymers 0.000 description 6
- 230000008439 repair process Effects 0.000 description 6
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 150000002978 peroxides Chemical class 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 238000004377 microelectronic Methods 0.000 description 4
- 210000000440 neutrophil Anatomy 0.000 description 4
- -1 oxygen radical species Chemical class 0.000 description 4
- CMFNMSMUKZHDEY-UHFFFAOYSA-N peroxynitrous acid Chemical compound OON=O CMFNMSMUKZHDEY-UHFFFAOYSA-N 0.000 description 4
- 238000001878 scanning electron micrograph Methods 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 230000000451 tissue damage Effects 0.000 description 4
- 231100000827 tissue damage Toxicity 0.000 description 4
- ORZHVTYKPFFVMG-UHFFFAOYSA-N xylenol orange Chemical compound OC(=O)CN(CC(O)=O)CC1=C(O)C(C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C=C(CN(CC(O)=O)CC(O)=O)C(O)=C(C)C=2)=C1 ORZHVTYKPFFVMG-UHFFFAOYSA-N 0.000 description 4
- 241000282412 Homo Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000013068 control sample Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 238000012377 drug delivery Methods 0.000 description 3
- 210000003722 extracellular fluid Anatomy 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000009545 invasion Effects 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 230000000399 orthopedic effect Effects 0.000 description 3
- 230000004792 oxidative damage Effects 0.000 description 3
- 238000010525 oxidative degradation reaction Methods 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 210000000707 wrist Anatomy 0.000 description 3
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 2
- 102000004020 Oxygenases Human genes 0.000 description 2
- 108090000417 Oxygenases Proteins 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 238000000149 argon plasma sintering Methods 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000008512 biological response Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000000254 damaging effect Effects 0.000 description 2
- 238000010502 deborylation reaction Methods 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000003269 fluorescent indicator Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 150000002390 heteroarenes Chemical class 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 150000002576 ketones Chemical group 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- 238000005477 sputtering target Methods 0.000 description 2
- 150000003457 sulfones Chemical group 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical group OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- 206010070245 Foreign body Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- RHLLDTPGTFRJDJ-UHFFFAOYSA-N OCl.OCl Chemical compound OCl.OCl RHLLDTPGTFRJDJ-UHFFFAOYSA-N 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical group 0.000 description 1
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- DYBXVITUBPGBBW-UHFFFAOYSA-N anthracen-1-ylboronic acid Chemical compound C1=CC=C2C=C3C(B(O)O)=CC=CC3=CC2=C1 DYBXVITUBPGBBW-UHFFFAOYSA-N 0.000 description 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 150000001543 aryl boronic acids Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000005621 boronate group Chemical group 0.000 description 1
- 125000005620 boronic acid group Chemical group 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 230000007248 cellular mechanism Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000004035 construction material Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 125000004438 haloalkoxy group Chemical group 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 150000002433 hydrophilic molecules Chemical class 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000003960 inflammatory cascade Effects 0.000 description 1
- 238000013101 initial test Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 150000004767 nitrides Chemical class 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 238000007539 photo-oxidation reaction Methods 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 238000002294 plasma sputter deposition Methods 0.000 description 1
- 238000000717 platinum sputter deposition Methods 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000036515 potency Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008458 response to injury Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 108010038196 saccharide-binding proteins Proteins 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical group 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 150000003462 sulfoxides Chemical group 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/07—Endoradiosondes
- A61B5/076—Permanent implantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/1459—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/028—Microscale sensors, e.g. electromechanical sensors [MEMS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/16—Details of sensor housings or probes; Details of structural supports for sensors
- A61B2562/162—Capsule shaped sensor housings, e.g. for swallowing or implantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/18—Shielding or protection of sensors from environmental influences, e.g. protection from mechanical damage
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Optics & Photonics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Emergency Medicine (AREA)
- Materials For Medical Uses (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161452893P | 2011-03-15 | 2011-03-15 | |
| US61/452,893 | 2011-03-15 | ||
| US201161527368P | 2011-08-25 | 2011-08-25 | |
| US61/527,368 | 2011-08-25 | ||
| PCT/US2012/029209 WO2012125814A2 (en) | 2011-03-15 | 2012-03-15 | Integrated catalytic protection of oxidation sensitive materials |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014514033A JP2014514033A (ja) | 2014-06-19 |
| JP2014514033A5 JP2014514033A5 (https=) | 2016-09-15 |
| JP6084172B2 true JP6084172B2 (ja) | 2017-02-22 |
Family
ID=46828999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013558170A Expired - Fee Related JP6084172B2 (ja) | 2011-03-15 | 2012-03-15 | 酸化感受性材料の統合的な触媒による保護 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US9681824B2 (https=) |
| EP (1) | EP2685884B1 (https=) |
| JP (1) | JP6084172B2 (https=) |
| KR (1) | KR101959067B1 (https=) |
| CN (1) | CN103533884B (https=) |
| AU (1) | AU2012229109A1 (https=) |
| CA (1) | CA2830432C (https=) |
| SG (1) | SG193496A1 (https=) |
| TW (1) | TWI592663B (https=) |
| WO (1) | WO2012125814A2 (https=) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10201935B2 (en) | 2007-03-19 | 2019-02-12 | Augustine Temperature Management LLC | Electric heating pad |
| US8283602B2 (en) | 2007-03-19 | 2012-10-09 | Augustine Temperature Management LLC | Heating blanket |
| US20150366367A1 (en) | 2007-03-19 | 2015-12-24 | Augustine Temperature Management LLC | Electric heating pad with electrosurgical grounding |
| EP2685884B1 (en) | 2011-03-15 | 2020-09-23 | Senseonics, Incorporated | Integrated catalytic protection of oxidation sensitive materials |
| US20140088383A1 (en) * | 2012-09-14 | 2014-03-27 | Senseonics, Incorporated | Integrated catalytic protection of oxidation sensitive materials |
| US11109779B2 (en) | 2012-12-28 | 2021-09-07 | Senseonics, Incorporated | Chemical modification of analyte permeable membrane for enhanced oxidative stability |
| JP2016508761A (ja) | 2012-12-28 | 2016-03-24 | センセオニクス，インコーポレーテッド | 酸化及び光学的安定性のための分析物浸透膜システム |
| WO2015027018A1 (en) * | 2013-08-21 | 2015-02-26 | Senseonics, Incorporated | Drug elution for in vivo protection of bio-sensing analytes |
| US9963556B2 (en) | 2013-09-18 | 2018-05-08 | Senseonics, Incorporated | Critical point drying of hydrogels in analyte sensors |
| JP6732654B2 (ja) * | 2014-02-19 | 2020-07-29 | マリンクロット ホスピタル プロダクツ アイピー リミテッド | 一酸化窒素に曝される電気化学ガスセンサーの長期の感度変動を補償する方法 |
| WO2015157684A1 (en) | 2014-04-10 | 2015-10-15 | Augustine Biomedical And Design, Llc | Underbody warming systems with core temperature monitoring |
| WO2016077742A1 (en) | 2014-11-13 | 2016-05-19 | Augustine Temperature Management, Llc | Heated underbody warming systems with electrosurgical grounding |
| US10553861B2 (en) | 2017-04-10 | 2020-02-04 | HHeLI, LLC | Battery with novel components |
| US9786910B2 (en) | 2015-11-16 | 2017-10-10 | HHeLI, LLC | Synthesized, surface-functionalized, acidified metal oxide materials for energy storage, catalytic, photovoltaic and sensor applications |
| WO2020252389A1 (en) | 2019-06-12 | 2020-12-17 | HHeLI, LLC | Blended active materials for battery cells |
| US20180000997A1 (en) * | 2016-06-29 | 2018-01-04 | Berlock Aps | Implantable Device Having an Outer Surface Comprising Gold and Its Use as an Anti-Migration Device |
| WO2018075657A1 (en) | 2016-10-18 | 2018-04-26 | Senseonics, Incorporated | Real time assessement of sensor performance and prediction of the end of the functional life of an implanted sensor |
| WO2018093945A1 (en) | 2016-11-15 | 2018-05-24 | Hheli, Llc. | A surface-functionalized, acidified metal oxide material in an acidified electrolyte system or an acidified electrode system |
| US12369824B2 (en) | 2017-04-19 | 2025-07-29 | Senseonics, Incorporated | Detecting and correcting for interference in an analyte monitoring system |
| CN115868982B (zh) | 2017-04-19 | 2025-10-10 | 传感技术股份有限公司 | 对分析物指示剂变化的检测和修正 |
| CA3172066A1 (en) | 2017-05-17 | 2018-11-22 | HHeLI, LLC | Battery with acidified cathode and lithium anode |
| CA3062617C (en) | 2017-05-17 | 2023-09-19 | HHeLI, LLC | A high capacity battery cell with low active material loading |
| US10978731B2 (en) | 2017-06-21 | 2021-04-13 | HHeLI, LLC | Ultra high capacity performance battery cell |
| KR102502966B1 (ko) | 2017-09-22 | 2023-02-23 | 에이치헬리, 엘엘씨 | 초 고용량 성능의 배터리 셀의 구성 |
| WO2019108641A1 (en) * | 2017-11-28 | 2019-06-06 | Senseonics, Incorporated | Analyte indicator integrated with a catalytically active material |
| KR102098078B1 (ko) * | 2018-07-13 | 2020-04-08 | 주식회사 엔게인 | 수화겔 및 이를 포함하는 글루코스 센서 |
| US11283267B2 (en) | 2018-09-10 | 2022-03-22 | HHeLI, LLC | Methods of use of ultra high capacity performance battery cell |
| JP7394850B2 (ja) * | 2018-11-02 | 2023-12-08 | センセオニクス，インコーポレーテッド | 分析物指示薬上の薬剤溶出マトリクス |
| EP3891498B1 (en) * | 2018-12-05 | 2025-04-30 | Senseonics, Incorporated | Reduction of in vivo analyte signal degradation using multiple metals |
| US10765580B1 (en) | 2019-03-27 | 2020-09-08 | Augustine Biomedical And Design, Llc | Patient securement system for the surgical trendelenburg position |
| EP3965657B1 (en) | 2019-05-08 | 2025-03-05 | Senseonics, Incorporated | Mediation of in vivo analyte signal degradation |
| US11963761B2 (en) | 2019-05-16 | 2024-04-23 | Senseonics, Incorporated | Mediation of in vivo analyte signal degradation |
| US12278342B2 (en) | 2019-06-12 | 2025-04-15 | HHeLI, LLC | Alkaline and acidified metal oxide blended active materials |
| EP4049032A1 (en) | 2019-10-25 | 2022-08-31 | Cercacor Laboratories, Inc. | Indicator compounds, devices comprising indicator compounds, and methods of making and using the same |
| IL273038B (en) | 2020-03-03 | 2022-02-01 | Ben Zion Karmon | bone graft |
| WO2023249893A1 (en) | 2022-06-23 | 2023-12-28 | Augustine Biomedical And Design, Llc | Patient securement system for the surgical trendelenburg position |
| US11844733B1 (en) | 2022-06-23 | 2023-12-19 | Augustine Biomedical And Design, Llc | Patient securement system for the surgical Trendelenburg position |
| US20240260861A1 (en) * | 2023-02-06 | 2024-08-08 | Senseonics, Incorporated | Reduction of in vivo analyte signal degradation using multiple metals |
| CN116392648B (zh) * | 2023-04-14 | 2024-08-23 | 中国科学院长春应用化学研究所 | 一种温度、炎症双响应性的抗凝复合涂层及其制备方法、应用 |
| US12458257B2 (en) | 2024-04-12 | 2025-11-04 | Glucotrack, Inc. | Implantable glucose sensors and methods of glucose measurement configured for minimal sensor surface obstruction |
| US20250387054A1 (en) * | 2024-06-25 | 2025-12-25 | Senseonics, Incorporated | Preventing yellowing and fluorescence in epoxide diamine networks |
Family Cites Families (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63291595A (ja) * | 1987-05-22 | 1988-11-29 | Meidensha Electric Mfg Co Ltd | 生体試料中のグルコ−スの測定方法 |
| US5517313A (en) | 1995-02-21 | 1996-05-14 | Colvin, Jr.; Arthur E. | Fluorescent optical sensor |
| US5772864A (en) | 1996-02-23 | 1998-06-30 | Meadox Medicals, Inc. | Method for manufacturing implantable medical devices |
| US5833603A (en) | 1996-03-13 | 1998-11-10 | Lipomatrix, Inc. | Implantable biosensing transponder |
| US8527026B2 (en) | 1997-03-04 | 2013-09-03 | Dexcom, Inc. | Device and method for determining analyte levels |
| US20050033132A1 (en) | 1997-03-04 | 2005-02-10 | Shults Mark C. | Analyte measuring device |
| US5910661A (en) | 1997-05-13 | 1999-06-08 | Colvin, Jr.; Arthur E. | Flourescence sensing device |
| US5894351A (en) | 1997-05-13 | 1999-04-13 | Colvin, Jr.; Arthur E. | Fluorescence sensing device |
| US5917605A (en) | 1997-05-13 | 1999-06-29 | Colvin, Jr.; Arthur E. | Fluorescence sensing device |
| US5922183A (en) | 1997-06-23 | 1999-07-13 | Eic Laboratories, Inc. | Metal oxide matrix biosensors |
| ES2227880T3 (es) | 1997-08-09 | 2005-04-01 | Roche Diagnostics Gmbh | Dispositivo de analisis para realizar analisis in vivo en el cuerpo de un paciente. |
| WO1999046600A1 (en) | 1998-03-11 | 1999-09-16 | Sensors For Medicine And Science, Inc. | Detection of analytes by fluorescent lanthanide chelates |
| US6304766B1 (en) | 1998-08-26 | 2001-10-16 | Sensors For Medicine And Science | Optical-based sensing devices, especially for in-situ sensing in humans |
| CN100385232C (zh) | 1998-08-26 | 2008-04-30 | 医药及科学传感器公司 | 基于光学的感测装置 |
| DE19855421C2 (de) * | 1998-11-02 | 2001-09-20 | Alcove Surfaces Gmbh | Implantat |
| US6189536B1 (en) * | 1999-04-15 | 2001-02-20 | Medtronic Inc. | Method for protecting implantable devices |
| US6400974B1 (en) | 2000-06-29 | 2002-06-04 | Sensors For Medicine And Science, Inc. | Implanted sensor processing system and method for processing implanted sensor output |
| US7553280B2 (en) | 2000-06-29 | 2009-06-30 | Sensors For Medicine And Science, Inc. | Implanted sensor processing system and method |
| KR100922146B1 (ko) | 2000-08-04 | 2009-10-19 | 센서즈 포 메드슨 앤드 사이언스 인코포레이티드 | 수성 환경에서의 분석물 검출 |
| US7470420B2 (en) * | 2000-12-05 | 2008-12-30 | The Regents Of The University Of California | Optical determination of glucose utilizing boronic acid adducts |
| US6800451B2 (en) | 2001-01-05 | 2004-10-05 | Sensors For Medicine And Science, Inc. | Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone |
| MXPA03010064A (es) | 2001-05-04 | 2004-03-09 | Sensors For Med & Science Inc | Dispositivo de deteccion electro-optico con canal de referencia. |
| TWI293363B (en) | 2001-12-11 | 2008-02-11 | Sensors For Med & Science Inc | High performance fluorescent optical sensor |
| KR20030055609A (ko) | 2001-12-27 | 2003-07-04 | 김재열 | 꼬임 방지형 원주 자동 용접장치 |
| SE0200269D0 (sv) * | 2002-01-31 | 2002-01-31 | Ellem Bioteknik Ab | Material for implantation |
| US20040063167A1 (en) | 2002-07-12 | 2004-04-01 | Peter Kaastrup | Minimising calibration problems of in vivo glucose sensors |
| CN1806475B (zh) | 2003-04-15 | 2013-07-03 | 医药及科学传感器公司 | 具有集成天线的印刷电路装置和具有集成印刷电路板天线的可植入传感器处理系统 |
| US7467003B2 (en) * | 2003-12-05 | 2008-12-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| US8282549B2 (en) | 2003-12-09 | 2012-10-09 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
| US7519408B2 (en) | 2003-11-19 | 2009-04-14 | Dexcom, Inc. | Integrated receiver for continuous analyte sensor |
| US20050095174A1 (en) * | 2003-10-31 | 2005-05-05 | Wolf David E. | Semipermeable sensors for detecting analyte |
| US8095197B2 (en) | 2003-11-03 | 2012-01-10 | Microchips, Inc. | Medical device for sensing glucose |
| US8165651B2 (en) | 2004-02-09 | 2012-04-24 | Abbott Diabetes Care Inc. | Analyte sensor, and associated system and method employing a catalytic agent |
| JP2005315871A (ja) * | 2004-03-31 | 2005-11-10 | Terumo Corp | 体内物質測定用構成物、体内物質測定用構成物の製造方法、および埋込型物質センサー |
| US7450980B2 (en) | 2004-03-31 | 2008-11-11 | Terumo Kabushiki Kaisha | Intracorporeal substance measuring assembly |
| US7713745B2 (en) * | 2004-04-13 | 2010-05-11 | Sensors For Medicine And Science, Inc. | Non-covalent immobilization of indicator molecules |
| US20050234316A1 (en) | 2004-04-16 | 2005-10-20 | Sensors For Medicine And Science, Inc. | Housing for a circuit that is to be implanted in-vivo and process of making the same |
| US7375347B2 (en) | 2004-04-26 | 2008-05-20 | Sensors For Medicine And Science, Inc. | Systems and methods for extending the useful life of optical sensors |
| US20070045902A1 (en) | 2004-07-13 | 2007-03-01 | Brauker James H | Analyte sensor |
| US7783333B2 (en) * | 2004-07-13 | 2010-08-24 | Dexcom, Inc. | Transcutaneous medical device with variable stiffness |
| US8073548B2 (en) | 2004-08-24 | 2011-12-06 | Sensors For Medicine And Science, Inc. | Wristband or other type of band having an adjustable antenna for use with a sensor reader |
| US8308794B2 (en) * | 2004-11-15 | 2012-11-13 | IZEK Technologies, Inc. | Instrumented implantable stents, vascular grafts and other medical devices |
| US7308292B2 (en) | 2005-04-15 | 2007-12-11 | Sensors For Medicine And Science, Inc. | Optical-based sensing devices |
| US20060282042A1 (en) | 2005-06-08 | 2006-12-14 | Sensors For Medicine And Science, Inc. | Insertion device and method |
| US20070014726A1 (en) | 2005-07-18 | 2007-01-18 | Sensors For Medicine And Science | Oxidation-resistant indicator macromolecule |
| EP1790977A1 (en) | 2005-11-23 | 2007-05-30 | SONY DEUTSCHLAND GmbH | Nanoparticle/nanofiber based chemical sensor, arrays of such sensors, uses and method of fabrication thereof, and method of detecting an analyte |
| US20100202966A1 (en) | 2006-03-28 | 2010-08-12 | Yossi Gross | Implantable Sensor |
| US20080125838A1 (en) | 2006-08-10 | 2008-05-29 | Medtronic, Inc. | Implantable Devices With Photocatalytic Surfaces |
| CN101541813B (zh) | 2006-11-30 | 2013-07-31 | 医药及科学传感器公司 | 耐氧化的指示剂分子 |
| KR20090127344A (ko) | 2007-03-08 | 2009-12-10 | 센서즈 포 메드슨 앤드 사이언스 인코포레이티드 | 가혹한 환경용 발광 다이오드 |
| CA2686065A1 (en) * | 2007-05-10 | 2008-11-20 | Glumetrics, Inc. | Equilibrium non-consuming fluorescence sensor for real time intravascular glucose measurement |
| AU2009276832A1 (en) | 2008-07-28 | 2010-02-04 | Sensors For Medicine & Science, Inc. | Systems and methods for optical measurement of analyte concentration |
| EP4549933A3 (en) | 2008-09-19 | 2025-05-21 | DexCom, Inc. | Particle-containing membrane and particulate electrode for analyte sensors |
| CA2757842A1 (en) * | 2009-04-09 | 2010-10-14 | The Children's Hospital Of Philadelphia | Ligand-specific inhibition of attachment of immune cells to implantable biomaterials |
| WO2010123972A1 (en) | 2009-04-21 | 2010-10-28 | Sensors For Medicine And Science, Inc. | Protective shell for an in vivo sensor made from resorbable polymer |
| WO2011097586A1 (en) * | 2010-02-08 | 2011-08-11 | Glumetrics, Inc. | Antioxidant protection of a chemical sensor |
| JP6008370B2 (ja) | 2010-02-16 | 2016-10-19 | ライトシップ メディカル リミテッド | グルコースセンサ用障壁層 |
| JP5101659B2 (ja) * | 2010-05-25 | 2012-12-19 | 株式会社東芝 | 血圧センサ |
| US20120053427A1 (en) | 2010-08-31 | 2012-03-01 | Glumetrics, Inc. | Optical sensor configuration and methods for monitoring glucose activity in interstitial fluid |
| WO2012048150A1 (en) | 2010-10-06 | 2012-04-12 | Profusa, Inc. | Tissue-integrating sensors |
| EP2685884B1 (en) | 2011-03-15 | 2020-09-23 | Senseonics, Incorporated | Integrated catalytic protection of oxidation sensitive materials |
| EP2744909B1 (en) | 2011-08-17 | 2021-09-22 | Baxter International Inc. | Method for preparing a barrier layer for a glucose sensor |
| CA3095821C (en) | 2012-03-15 | 2023-03-14 | Baxter International Inc. | Sensor |
-
2012
- 2012-03-15 EP EP12757630.4A patent/EP2685884B1/en active Active
- 2012-03-15 US US13/421,013 patent/US9681824B2/en active Active
- 2012-03-15 AU AU2012229109A patent/AU2012229109A1/en not_active Abandoned
- 2012-03-15 CA CA2830432A patent/CA2830432C/en active Active
- 2012-03-15 KR KR1020137027216A patent/KR101959067B1/ko not_active Expired - Fee Related
- 2012-03-15 TW TW101109012A patent/TWI592663B/zh not_active IP Right Cessation
- 2012-03-15 SG SG2013069745A patent/SG193496A1/en unknown
- 2012-03-15 CN CN201280023591.3A patent/CN103533884B/zh not_active Expired - Fee Related
- 2012-03-15 WO PCT/US2012/029209 patent/WO2012125814A2/en not_active Ceased
- 2012-03-15 JP JP2013558170A patent/JP6084172B2/ja not_active Expired - Fee Related
-
2017
- 2017-06-15 US US15/623,474 patent/US10674937B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012125814A2 (en) | 2012-09-20 |
| US20180146885A1 (en) | 2018-05-31 |
| CN103533884A (zh) | 2014-01-22 |
| WO2012125814A3 (en) | 2013-12-27 |
| EP2685884A2 (en) | 2014-01-22 |
| AU2012229109A1 (en) | 2013-10-10 |
| US20120238842A1 (en) | 2012-09-20 |
| JP2014514033A (ja) | 2014-06-19 |
| KR20140035892A (ko) | 2014-03-24 |
| CN103533884B (zh) | 2016-06-01 |
| CA2830432A1 (en) | 2012-09-20 |
| US10674937B2 (en) | 2020-06-09 |
| EP2685884B1 (en) | 2020-09-23 |
| TW201243332A (en) | 2012-11-01 |
| CA2830432C (en) | 2022-04-26 |
| EP2685884A4 (en) | 2015-04-15 |
| US9681824B2 (en) | 2017-06-20 |
| KR101959067B1 (ko) | 2019-03-15 |
| TWI592663B (zh) | 2017-07-21 |
| SG193496A1 (en) | 2013-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6084172B2 (ja) | 酸化感受性材料の統合的な触媒による保護 | |
| US20170202517A1 (en) | Integrated catalytic protection of oxidation sensitive materials | |
| US20200337619A1 (en) | Bio-adaptable implantable sensor apparatus and methods | |
| Corsi et al. | Bioresorbable nanostructured chemical sensor for monitoring of pH level in vivo | |
| DK2043511T3 (en) | Methods and Materials for Stabilizing Analyte Sensors | |
| Colvin et al. | Increased in vivo stability and functional lifetime of an implantable glucose sensor through platinum catalysis | |
| EP2744399B1 (en) | Control of biofouling in implantable biosensors | |
| CN109419515B (zh) | 具有分级激活的可植入化学传感器 | |
| US20100298674A1 (en) | Protective shell for an in vivo sensor made from resorbable polymer | |
| WO2003011354A3 (en) | Membrane for use with implantable devices | |
| Uzair et al. | Noninvasively imaging pH at the surface of implanted orthopedic devices with X-ray excited luminescence chemical imaging | |
| Pradhan et al. | Continuous monitoring of glucose and oxygen using an insertable biomaterial-based multianalyte barcode sensor | |
| JP2022506601A (ja) | 分析物指示薬上の薬剤溶出マトリクス | |
| US20240260861A1 (en) | Reduction of in vivo analyte signal degradation using multiple metals | |
| Frost et al. | In vivo sensors for continuous monitoring of blood gases, glucose, and lactate: biocompatibility challenges and potential solutions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150303 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150303 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160127 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160129 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160427 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160627 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160727 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20160727 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20161226 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170124 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6084172 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |